Berlin - Delayed Quote • EUR
Arbutus Biopharma Corp (I9DN.BE)
As of 8:08 AM GMT+2. Market Open.
Loading Chart for I9DN.BE
DELL
- Previous Close
2.5020 - Open
2.4900 - Bid 2.5360 x --
- Ask 2.5780 x --
- Day's Range
2.4900 - 2.4900 - 52 Week Range
1.4940 - 2.8080 - Volume
1,000 - Avg. Volume
0 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 2, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: I9DN.BE
Performance Overview: I9DN.BE
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
I9DN.BE
10.42%
S&P 500
7.04%
1-Year Return
I9DN.BE
2.35%
S&P 500
25.40%
3-Year Return
I9DN.BE
3.49%
S&P 500
22.14%
5-Year Return
I9DN.BE
4.56%
S&P 500
74.48%
Compare To: I9DN.BE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: I9DN.BE
Valuation Measures
As of 4/26/2024
Market Cap
458.05M
Enterprise Value
341.94M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
24.49
Price/Book (mrq)
4.55
Enterprise Value/Revenue
18.85
Enterprise Value/EBITDA
-4.82
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Company Insights: I9DN.BE
I9DN.BE does not have Company Insights